down arrow

Pharmarise Holdings Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802320006
  • TKS: 2796
JPY
504.00
-3 (-0.59%)

Sep 25

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Aug'26
May'26
Feb'26
Nov'25
Aug'25
May'25
Feb'25
Net Sales
17,242.00
18,956.00
16,954.00
16,849.00
16,753.00
16,929.00
16,035.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17,242.00
18,956.00
16,954.00
16,849.00
16,753.00
16,929.00
16,035.00
Raw Material Cost
15,221.00
16,649.00
14,791.00
14,721.00
14,715.00
14,710.00
13,926.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
95.00
93.00
69.00
62.00
61.00
59.00
51.00
Selling and Distribution Expenses
1,952.00
1,932.00
1,957.00
1,882.00
1,885.00
2,021.00
2,113.00
Other Expenses
-9.50
-9.30
-6.90
-6.20
-6.10
-5.90
-5.10
Total Expenditure (Excl Depreciation)
17,173.00
18,581.00
16,748.00
16,603.00
16,600.00
16,731.00
16,039.00
Operating Profit (PBDIT) excl Other Income
69
375
206
246
153
198
-4
Other Income
13.00
13.00
-47.00
6.00
39.00
17.00
8.00
Operating Profit (PBDIT)
479.00
842.00
544.00
642.00
568.00
623.00
386.00
Interest
95.00
93.00
69.00
62.00
61.00
59.00
51.00
Exceptional Items
92.00
-34.00
-20.00
45.00
1.00
-118.00
-15.00
Gross Profit (PBDT)
2,021.00
2,307.00
2,163.00
2,128.00
2,038.00
2,219.00
2,109.00
Depreciation
397.00
454.00
385.00
390.00
376.00
408.00
382.00
Profit Before Tax
78.00
264.00
66.00
237.00
131.00
36.00
-62.00
Tax
117.00
137.00
193.00
108.00
153.00
135.00
99.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-37.00
126.00
-123.00
129.00
-19.00
-96.00
-158.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-37.00
126.00
-123.00
129.00
-19.00
-96.00
-158.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.00
0.00
-2.00
-1.00
-3.00
-1.00
-5.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-38.00
126.00
-125.00
128.00
-22.00
-97.00
-163.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,642.00
6,842.00
6,687.00
6,815.00
6,617.00
6,869.00
6,948.00
Earnings per share (EPS)
-3.13
10.7
-10.78
10.93
-1.58
-8.36
-14.0
Diluted Earnings per share
-3.13
10.7
-10.78
10.93
-1.58
-8.36
-14.0
Operating Profit Margin (Excl OI)
0.4%
1.98%
1.22%
1.46%
0.91%
1.17%
-0.02%
Gross Profit Margin
2.75%
3.79%
2.66%
3.72%
3.03%
2.62%
2.0%
PAT Margin
-0.21%
0.66%
-0.73%
0.77%
-0.11%
-0.57%
-0.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Aug 2026 is -9.04% vs 11.81% in May 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Aug 2026 is -130.16% vs 200.80% in May 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Aug 2026 is -43.79% vs 40.27% in May 2026

stock-summary

Interest

QoQ Growth in quarter ended Aug 2026 is 2.15% vs 34.78% in May 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Aug 2026 has fallen from May 2026

Compare Quarterly Results Of Pharmarise Holdings Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
17,242.00
10.00
17,232.00
172,320.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
17,242.00
10.00
17,232.00
172,320.00%
Raw Material Cost
15,221.00
1.58
15,219.42
963,254.43%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
95.00
0.00
95.00
Selling and Distribution Expenses
1,952.00
48.70
1,903.30
3,908.21%
Other Expenses
-9.50
4.18
-13.68
-327.27%
Total Expenditure (Excl Depreciation)
17,173.00
92.09
17,080.91
18,548.06%
Operating Profit (PBDIT) excl Other Income
69.00
-82.09
151.09
184.05%
Other Income
13.00
0.30
12.70
4,233.33%
Operating Profit (PBDIT)
479.00
-81.77
560.77
685.79%
Interest
95.00
0.00
95.00
Exceptional Items
92.00
0.00
92.00
Gross Profit (PBDT)
2,021.00
8.42
2,012.58
23,902.38%
Depreciation
397.00
0.02
396.98
1,984,900.00%
Profit Before Tax
78.00
-81.79
159.79
195.37%
Tax
117.00
0.25
116.75
46,700.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-37.00
-82.04
45.04
54.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-37.00
-82.04
45.04
54.90%
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.00
0.00
-1.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-38.00
-82.04
44.04
53.68%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,642.00
3,240.64
3,401.36
104.96%
Earnings per share (EPS)
-3.13
-5.95
2.82
47.39%
Diluted Earnings per share
-3.13
-5.95
2.82
47.39%
Operating Profit Margin (Excl OI)
0.40%
-820.93%
0.00
821.33%
Gross Profit Margin
2.75%
-817.71%
0.00
820.46%
PAT Margin
-0.21%
-820.40%
0.00
820.19%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,724.20 Million
in Aug 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Aug 2026 is -9.04% vs 11.81% in May 2026

stock-summary

YoY Growth in quarter ended Aug 2026 is 2.92% vs 9.99% in Aug 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -3.80 Million
in Aug 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Aug 2026 is -130.16% vs 200.80% in May 2026

stock-summary

YoY Growth in quarter ended Aug 2026 is -72.73% vs 83.46% in Aug 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.60 Million
in Aug 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Aug 2026 is -43.79% vs 40.27% in May 2026

stock-summary

YoY Growth in quarter ended Aug 2026 is -11.91% vs 33.25% in Aug 2025

Quarterly - Interest
Interest 9.50 Million
in Aug 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Aug 2026 is 2.15% vs 34.78% in May 2026

stock-summary

YoY Growth in quarter ended Aug 2026 is 55.74% vs 103.33% in Aug 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.40%
in Aug 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Aug 2026 has fallen from May 2026

stock-summary

YoY Growth in quarter ended Aug 2026 has fallen from Aug 2025

Footer loading